As a UT MD Anderson volunteer, Leslie Cromeans finds joy in connecting with patients and caregivers in the Art Space. Her drawings offer them a creative outlet while she fosters a safe space for communication.

Breast cancer isn’t always a lump. Nine survivors share how they knew something was wrong, and breast medical oncologist Oluchi Oke, M.D., explains the warning signs.

Ashley Zaldivar resisted getting a gastrectomy until her mother died of a stomach cancer linked to the genetic mutation they shared. Today, she promotes genetic testing to boost awareness of CDH1.

At the American Society for Radiation Oncology (ASTRO) Annual Meeting, UT MD Anderson experts showcase their pacesetting research and join colleagues for discussion on the latest advances in radiation oncology.

Radiation oncology leader Prajnan Das, M.D., shares selections for the top abstracts that will be presented by UT MD Anderson researchers at this year’s American Society for Radiation Oncology (ASTRO) Annual Meeting.

Albert Koong, M.D., Ph.D., was officially appointed UT MD Anderson's Chief Scientific Officer in June 2026. He discusses his career, passions and the future of cancer research.

Elizabeth Jardinella was diagnosed with ovarian cancer at 25. After joining a clinical trial at UT MD Anderson, she is now cancer-free and has become an advocate for women’s health.

Neuropathy is the clinical term for nerves that are not working properly. Moran Amit, M.D., Ph.D., discusses causes, symptoms and advances in neuropathy prevention.

It’s estimated that more than 1 million patients with cancer have benefited from immunotherapy. But Nobel Laureate James P. Allison, Ph.D., knows there’s more work to be done. That’s why UT MD Anderson’s James P. Allison Institute is working to bring the benefits of immunotherapy to all patients.

After being diagnosed with acute myeloid leukemia at age 50, Leigh Ann Chiles sought treatment at UT MD Anderson. A clinical trial only available here helped lead her to complete remission, and she made lasting connections.

What does it mean if your HPV and/or Pap test results are abnormal? Gynecologic oncologist Kathleen Schmeler, M.D., explains the connection between abnormal screening results and cervical cancer.

Most thyroid nodules aren't cancerous, and many never need treatment. Oncologic endocrinologist Steven Weitzman, M.D., explains how thyroid nodules are diagnosed, when they need treatment and when they can be safely monitored.

The University of Texas MD Anderson Cancer Center and Springer Nature will co-host a conference to explore the latest research on cancer therapeutics, highlighting advances in the development of next-generation treatment modalities and the technologies enabling them. “Next Generation Cancer Therapeutics” is scheduled for Oct. 6-8, 2026, on the UT MD Anderson campus.

After being diagnosed with cancer of unknown primary, John Clark III chose UT MD Anderson for a second opinion. Here, Kanwal Raghav, M.D., developed a treatment plan that has helped John remain cancer-free for over two years.

Wearable health monitoring devices can help track your activity, sleep and heart health. Karen Basen-Engquist, Ph.D. explains their benefits and limitations.

Barrett’s esophagus is a precancerous condition linked to acid reflux and GERD. Marta Davila, M.D., explains symptoms, cancer risk, diagnosis and treatment options.

Padmanee Sharma, M.D., Ph.D., has spent her career advancing immunotherapy to benefit cancer patients. Now, she’s focused on supporting up-and-coming researchers to drive even greater breakthroughs for cancer patients.

A rectal cancer diagnosis brought Chris Gibson to UT MD Anderson for a second opinion. Here he found a care team that listened to him and developed a plan to successfully treat the cancer.

In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated treatment cycles, which could help prevent pain, numbness and other common chemotherapy side effects.

Glycemic index measures how quickly foods with carbohydrates raise your blood sugar. Nupur Kikani, M.D., explains how it works and why it’s useful.

Leslie Mellinger came to UT MD Anderson with an anaplastic thyroid cancer diagnosis and a poor prognosis. Here, she found a caring team of individuals who helped her get more time with her family.

UT MD Anderson science teams are shifting their focus away from disease-specific research to focusing more on addressing questions that span multiple cancer types. The goal? To make a greater impact for cancer patients. Learn about some of the exciting research that’s ahead.

Blue light can interfere with sleep, but do blue light filters help? Learn what the research says and the sleep habits that are proven to improve sleep quality.

Gladys Gakuu came to UT MD Anderson for a second opinion after a breast cancer recurrence in 2020. Since completing treatment, she’s shown no evidence of disease.

Broken heart syndrome weakens the heart muscle after severe stress. Cardiologist Leslie Ynalvez, M.D., shares symptoms, treatment and prognosis.

Lorie Young has NTRK1 fusion, a genetic abnormality so rare it shows up in only about 0.2% of all lung cancer diagnoses. But at UT MD Anderson, she found a Phase 2 clinical trial that targets that exact mutation — and a new appreciation for the power of research.

Are you ever too old to donate blood? Can you still give blood even if you have tattoos or piercings? Here, transfusion specialist Joanne Becker, M.D., debunks these and two other myths around blood donation to get you back to giving back.

What does MMR deficiency mean for colorectal cancer patients? S. Daniel Haldar, M.D., explains testing, the link to Lynch syndrome and how MMR status helps determine who will benefit from immunotherapy.

An initial breast cancer diagnosis led Alabama mother Tiffany Andrews to UT MD Anderson for chemotherapy and surgery. When the cancer returned and spread to her lungs, she found hope in a UT MD Anderson clinical trial for patients with HER2 positive metastatic breast cancer.

Diabetes symptoms can be subtle and easy to miss. Nupur Kikani, M.D., explains the early warning signs, blood sugar levels and when to see a doctor.

Not sure how to start a fitness routine? Karen Basen-Engquist, Ph.D., discusses exercise types, as well as how to set realistic goals and build lasting habits.

Joseph Lecak came to UT MD Anderson with a pancreatic cancer diagnosis. After undergoing personalized treatment, he has shown no evidence of disease and has a good quality of life.

Taking a GLP-1 before surgery? Anesthesiologist Shannon Popovich, M.D., explains the aspiration risk and what steps to take to stay safe.

After receiving a prostate cancer diagnosis, Bob Barnes chose UT MD Anderson for treatment. Today, the longtime community leader and chairman and CEO of IBC Bank–Austin combines his personal cancer connection with a passion for philanthropy, recently helping raise nearly $300,000 through a charity golf tournament to support UT MD Anderson’s mission.

Every name tells a story. Every step makes a difference. Join UT MD Anderson for Boot Walk to End Cancer® on Nov. 14, 2026. Thousands will come together to support cancer patient care, research, prevention and education. Learn more and register at http://spr.ly/63329B1j0IN. #cancer #cancerawareness #cancercommunity #MDAnderson #EndCancer

 Urologic oncologist Matthew Campbell, M.D., and urologist Ashish Kamat, M.D., share three reasons why getting an accurate bladder cancer diagnosis is so important.

It took Naomi Arbel-Brodd 20 years to keep a promise she made to herself during breast cancer treatment. Now, the volunteer shares hope with other patients at UT MD Anderson, just as someone did with her, back in 2006.

Is your blood pressure only high at the doctor’s office? Carl Zehner, M.D., explains white coat hypertension, its risks and how to manage it.

After a colorectal cancer recurrence, Cindy Mette became the first patient on a Phase 1 clinical trial testing a new type of drug called a Werner helicase inhibitor.

Too busy for meal prep? Wellness dietitian Lindsey Wohlford shares a simpler approach to healthy eating.

Benign tumors are noncancerous, and malignant tumors are cancerous – but it’s not always that simple. UT MD Anderson expert Matthew Wright, M.D., explains the key differences.

 Urologic oncologist Lisly Chéry, M.D., and general oncologist Amy Hassan, M.D., explore why men are reluctant to go to the doctor — and three approaches to get them there.

Preparing for a colonoscopy allows your care team the best chance to spot any abnormalities. Here, UT MD Anderson gastroenterologist Lavanya Viswanathan, M.D., shares tips to make colonoscopy preparation easier.

Sepsis is a serious condition where the immune system's response to infection harms the body's tissues and organs. Cancer patients are especially vulnerable, as treatments like chemotherapy can weaken the immune system. Learn the signs and symptoms of sepsis and how to take preventative measures from UT MD Anderson expert Imrana Malik, M.D.

 A cytokine storm is a severe immune response that causes life-threatening inflammation. Elias Jabbour, M.D., explains causes, symptoms and treatment.

When Randy Hemingway received his second cancer diagnosis, he came to UT MD Anderson to explore the top treatment options available. Here’s how proton therapy under the care of Steven Frank, M.D., helped him become cancer-free.

What is a BOSU ball, and should you be using one? Wellness specialist Carlos Duncan weighs in.